Get started
Author

Adeel M. Khan

Correction: BRIDGE−2M: Optimizing Bridging Therapy Prior to CAR-T Therapy in Multiple Myeloma: A Modified Double-Blind Delphi Panel of US Physicians
2026 · Rahul Banerjee, Hamza Hashmi, et al. · Advances in Therapy
PDF
BRIDGE-2M: Optimizing Bridging Therapy Prior to CAR-T Therapy in Multiple Myeloma: A Modified Double-Blind Delphi Panel of US Physicians
2026 · Rahul Banerjee, Hamza Hashmi, et al. · Advances in Therapy
PDF
BCMA-targeted bispecific antibodies in relapsed/refractory multiple myeloma: three approvals, many questions
2026 · Samer Al Hadidi, Adeel M Khan, et al. · The Oncologist
The Safety and Efficacy of Commercial BCMA‐Directed CAR T‐Cell Therapy in Systemic AL Amyloidosis With Concurrent Myeloma
2026 · Matthew J. Rees, Raffaella Cassano Cassano, et al. · American Journal of Hematology
Total Marrow and Lymphoid Irradiation: A New Paradigm in Conditioning Intensity for Allogeneic Stem Cell Transplantation in Acute Leukemia and Myelodysplastic Syndrome across the Age Spectrum
2026 · Julio Alvarenga Thiebaud, Malgorzata Kozak, et al. · Transplantation and Cellular Therapy
B cell Repertoire Recovery Following Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma: Information from Minimal Residual Disease (MRD) Testing
2026 · Elissa Brunaugh, Bethany Gardner, et al. · Transplantation and Cellular Therapy
Multi-System Biological Age Reversal Following MUSE Stem Cell Therapy: Case Reports
2025 · Adeel Khan, Ramiz Malik · Mathews Journal of Case Reports
PDF
Works count: 7
Citation count:
H-index:
I10-index:
Year
Topic
Type